EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2025 Earnings Call Transcript May 7, 2025
EyePoint Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.65 EPS, expectations were $-0.65.
Operator: Good morning. My name is Towanda and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint First Quarter 2025 Financial Results and Recent Corporate Developments Conference Call. There will be a question-and-answer...
